
无数据
无数据
无数据
| CAS Number | 7491-74-9 |
| Catalog Number | AG00ICKN(AGN-PC-0BF6K4) |
| Chemical Name | 1-Pyrrolidineacetamide, 2-oxo- |
| EC Number | 231-312-7 |
| IUPAC Name | 2-(2-oxopyrrolidin-1-yl)acetamide |
| InChI | InChI=1S/C6H10N2O2/c7-5(9)4-8-3-1-2-6(8)10/h1-4H2,(H2,7,9) |
| InChI Key | GMZVRMREEHBGGF-UHFFFAOYSA-N |
| MDL Number | MFCD00079246 |
| Molecular Formula | C6H10N2O2 |
| Molecular Weight | 142.1558 |
| NSC Number | 758191 |
| SMILES | O=C1N(CCC1)CC(N)=O |
| UNII | ZH516LNZ10 |
| Synonyms | 2-Pyrrolidone-N-Acetamide,
Avigilen,
Axonyl,
Cerebroforte,
Cerepar N,
Ciclofalina,
Cuxabrain,
Dinagen,
Gabacet,
Geram,
Memo Puren,
Memo-Puren,
Nootrop,
Nootropil,
Nootropyl,
Normabraïn,
Piracebral,
Piracetam,
Piracetam AbZ,
Piracetam RPh,
Piracetam-RPh,
Piracetrop,
Pirazetam,
Pyracetam,
Pyramem,
Sinapsan,
UCB 6215,
UCB-6215,
UCB6215,
piracetam,
7491-74-9,
2-(2-oxopyrrolidin-1-yl)acetamide,
Nootropil,
2-Oxo-1-pyrrolidineacetamide,
Nootropyl,
Pyracetam,
Normabrain,
Gabacet,
Pyramem,
1-Pyrrolidineacetamide, 2-oxo-,
Ciclofalina,
Genogris,
Pirazetam,
Pirroxil,
Euvifor,
Nootron,
2-Pyrrolidinoneacetamide,
2-Oxo-pyrrolidine acetamide,
2-Pyrrolidoneacetamide,
UCB 6215,
Naofukang [Chinese],
1-Acetamido-2-pyrrolidinone,
2-(2-oxo-pyrrolidin-1-yl)acetamide,
2-Oxo-pyrrolidin-1-ylacetamide,
2-Ketopyrrolidine-1-ylacetamide,
Cl-871,
Piracetamum [INN-Latin],
UNII-ZH516LNZ10,
KT-801,
MLS000069719,
2-(2-Oxo-1-pyrrolidinyl)acetamide,
EINECS 231-312-7,
BRN 1526393,
SMR000058196,
2-(2-Oxopyrrolidino)acetamide,
ZH516LNZ10,
GMZVRMREEHBGGF-UHFFFAOYSA-N,
NCGC00015821-02,
CAS-7491-74-9,
2-(2-oxidanylidenepyrrolidin-1-yl)ethanamide,
DSSTox_CID_24491,
DSSTox_RID_80267,
DSSTox_GSID_44491,
2-(2-oxopyrrolidinyl)acetamide,
Cerebroforte,
Piracetamum,
Avigilen,
Breinox,
Naofukang,
Nootrop,
Axonyl,
Geram,
SR-01000076071,
2-Pyrrolidone-N-Acetamide,
Encetrop,
Norzetam,
Piracetam [USAN:BAN:INN],
Piracetam [USAN:INN:BAN],
HSDB 7529,
Piracetam,(S),
UCB-6215,
Prestwick_870,
Myocalm (TN),
Deshydroxy Oxiracetam,
Spectrum_001421,
Opera_ID_1766,
Prestwick0_000537,
Prestwick1_000537,
Prestwick2_000537,
Prestwick3_000537,
Spectrum2_001074,
Spectrum3_001523,
Spectrum4_000742,
Spectrum5_001037,
Lopac-P-5295,
ssAA-I/I(1),
AC1L1J2W,
cid_4843,
Lopac0_000949,
Oprea1_512927,
SCHEMBL20172,
BSPBio_000553,
BSPBio_002906,
KBioGR_001064,
KBioSS_001901,
5-21-06-00360 (Beilstein Handbook Reference),
Piracetam (JAN/USAN/INN),
CHEMBL36715,
DivK1c_000259,
SPECTRUM1502195,
SPBio_001088,
SPBio_002474,
2-(2-ketopyrrolidino)acetamide,
BPBio1_000609,
GTPL4288,
DTXSID5044491,
BDBM62877,
CHEBI:32010,
Cl-781,
CTK7D3269,
HMS500M21,
KBio1_000259,
KBio2_001901,
KBio2_004469,
KBio2_007037,
KBio3_002406,
NINDS_000259,
HMS1569L15,
HMS1921L12,
HMS2092D18,
HMS2096L15,
HMS2230B24,
HMS3262N20,
HMS3371G01,
HMS3657A05,
HMS3713L15,
Pharmakon1600-01502195,
BCP28414,
HY-B0585,
KS-00000K5B,
ZINC3812874,
Tox21_110229,
Tox21_301990,
Tox21_500949,
BBL028161,
CCG-39282,
MFCD00079246,
NSC758191,
s3070,
SBB086233,
STK535612,
2 - Oxo - 1 - pyrrolidineacetamide,
AKOS001038683,
Tox21_110229_1,
2-(2-Oxo-1-pyrrolidinyl)acetamide #,
CS-2774,
DB09210,
LP00949,
MCULE-7645397226,
NSC-758191,
IDI1_000259,
NCGC00015821-01,
NCGC00015821-03,
NCGC00015821-04,
NCGC00015821-05,
NCGC00015821-06,
NCGC00015821-07,
NCGC00015821-08,
NCGC00015821-10,
NCGC00094253-01,
NCGC00094253-02,
NCGC00094253-03,
NCGC00094253-04,
NCGC00255727-01,
NCGC00261634-01,
AK326212,
AS-13920,
BC204713,
K282,
SC-78454,
SBI-0050923.P003,
AB0014139,
AB1009436,
DB-019407,
LS-137082,
TX-017921,
AB00052287,
EU-0100949,
FT-0636504,
ST50182453,
SW196995-3,
Piracetam, VETRANAL(TM), analytical standard,
D01914,
M-3297,
P 5295,
96625-EP2287163A1,
96625-EP2305678A1,
AB00052287_12,
A838261,
AE-641/30117005,
I05-0236,
SR-01000076071-1,
SR-01000076071-4,
SR-01000076071-6,
W-104408,
BRD-K19456237-001-22-7,
Z56865289,
Piracetam, European Pharmacopoeia (EP) Reference Standard,
2-(2-Oxopyrrolidino)acetamide; 2-Oxo-1-pyrrolidineacetamide,
2-No u-1-ssA inverted question mark(c)IeOOo pound degrees .,
Breinox, Dinagen, Lucetam, Nootropil, Nootropyl, Oikamid, and many others,
neuracetam,
Piracebral,
Piracetrop,
Cuxabrain,
Sinapsan,
Dinagen,
Myocalm,
Piracetam AbZ,
Piracetam RPh,
Piracetam-RPh,
Memo Puren,
Memo-Puren,
Cerepar N,
D0Q4YK,
C6H10N2O2,
2-Oxo-1-pyrrolidineacet-amide,
CID4843,
UCB6215,
C6-H10-N2-O2,
CS-O-00247,
B2006,
Piracetam, 2-Oxo-1-pyrrolidineacetamide, EP6.0,
D010889,
PZI,
|
| Complexity | 167 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 142.074g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 10 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 142.158g/mol |
| Monoisotopic Mass | 142.074g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 63.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H317 |
| Packing Group | |
| Precautionary statements | P280 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

